About the Journal

About BTL

The Biomedical and Therapeutics Letters is a top-tier venue for discoveries in the field of biomedical science, medical biotechnology, medical microbiology, genetics, clinical reports, medical sciences, and in basic and applied biomedical research covering recent advances in drugs and therapeutics development. The BTL:

• would provide all contents online for wide circulation and get contents indexed in different scientific content databases.
• provides free access to all of its research articles for one or more months for each issue,
• would deposit published research articles in different databases and would satisfy the NIH Public Access Policy guidelines.
• is an ideal home for authors seeking the broadest audience for their most important work.

The journal is led by Editors and supported by Editorial Advisory Board of peer scientists from various reputed universities, research institutes and other reputed Medical Research Institutes whose depth and experience ensure fair and competent peer review.

Sending your work to the BTL

The journal considers research submissions in several categories. The BTL receives submissions only through its website; submissions by mail or e-mail will be returned.

• Create or access your BTL author account

Do you have a question about a manuscript you've already submitted?

• When a manuscript is received and confirmed by the BTL, an acknowledgment is sent via e-mail to the corresponding author. For any communication with us, please reference the tracking number assigned by the BTL noted in the acknowledgment.
• In order to avoid confusion regarding correspondence, inquiries, and decisions, the BTL will typically communicate only with those who are designated as corresponding authors during the submission process.

Manuscript submitted and processed for reviewing can't be withdrawn. If authors do not respond to emails for the reviewed and accepted manuscript, then the article will be published by the journal in unedited format with a note 'withdrawn by authors' by no response.

Unique IDs for Articles: The journal is currently using URN number for the published articles (however, this is currently meant for internal use by the journal). The journal will also process the assigning of DOI (Digital Object Identifier) to articles (including previously published ones) once the journal is indexed in Web of Science (Clarivate) as it helps in providing the correct citations records for the published articles.

The submission are peer reviewed by using standard review procedure.

Single Blind Review Process: The reviewers will have access to submitted files and provide feedback within the assigned time.

Standard Review Process
Editors will email selected Reviewers the title and abstract of the submission, as well as an invitation to log into the journal web site to complete the review. Reviewers enter the journal web site to agree to do the review, view the declared ethical guidelines for reviewers, declare 'conflict of interest' (if any), to download submissions, submit their comments, and select a recommendation.

Average time from submission to first decision is 6-10 weeks.

--------------

Publication Ethics and Publication Malpractice Statement

The Journal ‘Biomedical and Therapeutics Letters’ and its Publisher ‘The ScienceIn’ follows the best practices in evaluation of contents, processing of manuscripts and publishing thereof. The Journal and Publisher essentially follows the code of conduct defined by Committee on Publication Ethics (COPE) for Journal Editors (Code of Conduct and Best Practices Guidelines for Journal Editors listed in COPE guidelines and Publisher (the Code of Conduct Journal Publishers listed in COPE page COPE site

Further, the journal publishes biomedical and clinical reports, so the journal adheres and follows the guidelines defined for publication in medical journals by International Committee of Medical Journal Editors (ICMJE) in its document ‘Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals’ provided on link http://www.icmje.org/recommendations and World Association of Medical Editors (WAME) on its webpage http://www.wame.org/

The Authors, Reviewers and Editors need to adhere and follow the code of conduct on ethical practices defined at above mentioned links in the respective roles. The clinical studies related works need to follow the ethical guidelines provided by World Association of Medical Editors (WAME) on its webpage http://www.wame.org/

Ethical Approvals
Patient Rights: Patients have the right to privacy; therefore, all studies must be conducted with informed consent. Identifiable information should not be included in written descriptions, photographs, or pedigrees unless it is crucial for scientific purposes and the patient (or their parent or guardian) provides written informed consent for publication. When informed consent is obtained, it should be clearly indicated in the article. Research involving human subjects must adhere to the ethical standards outlined in the Helsinki Declaration of 1964, as revised in 2000. All experiments must also receive approval from the institutional human experimentation committee or an equivalent body.

Animal Rights:Animal experiments must follow the ethical standards for the care and use of laboratory animals. The article involved animal experiments and must seek approval(s) from the appropriate Ethical Committee in accordance with the "Guide for the Care and Use of Laboratory Animals" and CPCSEA guidelines. A statement on ethics committee permission must be included in all research articles.

Clinical trial registry:The journal recommends that the clinical trials should be registered in a publicly accessible database. Authors should include the clinical trial registration numbers on all papers that report their results. The authors must adhere to the minimum set of recommendations for reporting randomized trials as described in "The CONSORT (CONsolidated Standards of Reporting Trials) 2010 guideline".

The manuscript processing involves following stages

In addition, general instructions and help pages on ‘The ScienceIN’ for Authors, Reviewers and Editors should be referred for general conduct.

Authors

Each author who submits (and willing to publish in the journal) the manuscript, should read the ethical guidelines for submission and publication of work in scientific and medical journals (listed on above links). Particularly, manuscripts must be plagiarism free. Any Animal study reported should have been performed with approval of respective institutional ethical committee and statement thereof should be included in manuscript.

Author Guidelines for manuscript preparation and submission details are provided under Author Guidelines (See submission link).

The authors should refer the publishing ethics or 'Code of conduct' and 'conflict on interest' guidelines on the link: https://pubs.thesciencein.org/authors-code-of-conduct/

Reviewer

The journal uses ‘Single Blind Review’ of the manuscripts, the reviewers must maintain confidentiality during reviewing and post review of manuscript. The manuscript work should be evaluated in respective fields of expertise and detailed feedback and recommendation should be provided to editors. The general code of conduct defined in links below should be referred to and followed while reviewing and providing feedback.

The ethics guidelines/code of conduct details for reviewers can be referred at https://pubs.thesciencein.org/reviewers-code-of-conduct/

Editors

All the editors should handle the assigned manuscripts by observing fair processing of submissions, editorial independence, confidentiality, and rational decision making within a stipulated time framework with the feedback obtained from independent reviewer/experts in the field of work covered in the respective manuscript. A detailed code of conduct mentioned in COPE reference documents and ScienceIn page https://pubs.thesciencein.org/editors-code-of-conduct/ should be adhered to.

Publisher

The Publisher ‘The ScienceIn’ handles the unethical publishing cases. In cases of alleged or proven scientific misconduct, fraudulent publication or plagiarism, the publisher, in close collaboration with the editors, will take all appropriate measures to clarify the situation and to amend the article in question. This includes the prompt publication of an erratum, clarification or, in the most severe case, the retraction of the affected work. The publisher, together with the editors, shall take reasonable steps to identify and prevent the publication of papers where research misconduct has occurred, and under no circumstances encourage such misconduct or knowingly allow such misconduct to take place.

Access to journal content: The publisher is committed to the permanent availability and preservation of scholarly research. The online and digital contents are preserved by the Publisher by maintaining its own digital archive and would also ensure accessibility by partnering with other digital archiving organizations. Most of the journal contents are archived in the Print form as well.